The rationale of the ASSET project's approach is that we could therapeutically exploit the common pathways that malfunction in cancers for targeted treatment. Embryonal tumours (ETs) are being used as the paradigm of early genetic alterations to gain important insight into the pathogenesis in cancer.
Further information: cordis.europa.eu